Trial Details

COMPLETED
Basic Information
Clinical ID c4163
Identifier NCT00950105
Trial Title Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: CPSI-2364 or placebo
Participant Information
Sponsor Ferring Pharmaceuticals
City Overland Park
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2009-07
Primary Completion Date 2009-10
Completion Date 2009-10